9th AMR Conference: Novel Antimicrobials & AMR Diagnostics
The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market. The conference is the one-stop shop to catch up with the latest trends in the development of AMR […]
Lessons Learned for AMR Independent Panel
In cooperation with the Quadripartite, representatives from The University in Ibadan, The Center for Global Development, and Boston University will collaboratively lead a strategic dialogue to document and analyze lessons learned from previous initiatives, such as IPCC. This dialogue will bring together a globally representative group of scientists and science academies.
Evidence for Action (E4A) Dialogue on Antimicrobial Resistance
Boston University Law School Professor Kevin Outterson will co-host this event with Hon. Dr. Chris Fearne MP, Deputy Prime Minister of Malta, and Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance (AMR). The conference will identify the most pressing questions from AMR champions in political and policy circles, and connect those questions with top-level researchers who will either point to existing data or trigger new research to fill the gaps.
BIO International Convention
Kevin Outterson will speak at the BIO International Convention from June 5th through 8th. Hosted in Boston, the BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Innovative programming around the current and future state of biotech, including areas like therapeutic frontiers, […]
Repairing the broken business model for antimicrobial R&D
Kevin Outterson will speak at the CPRT Open Webinar on “Repairing the broken business model for antimicrobial R&D”. The virtual talk is hosted by UMass Lowell Center for Pathogen Research and Training, and will start at 3:30 on September 14, 2022. The Zoom ID for this event is: 953 7011 3908.
Solutions to AMR from the Social Sciences
Kevin Outterson will speak at “Solutions to AMR from the Social Sciences”, hosted by CeBIL (University of Copenhagen), INAMRSS and the Global Strategy Lab (York University), in collaboration with the Social Innovation on Drug Resistance Program (Boston University) & the AMR Centre (London School of Hygiene & Tropical Medicine). The conference will take place at […]
A Grand Bargain for Antimicrobial Procurement: Leveraging Purchasing Systems to Address AMR
Kevin Outterson will speak as a panelist for “A Grand Bargain for Antimicrobial Procurement: Leveraging Purchasing Systems to Address AMR” presented by the Center for Global Development on June 30th from 9:00-10:00 am eastern time. This conversation will cover new purchasing systems for antimicrobials and the grand bargain stakeholders must strike to govern the global […]
Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicine
The centerpiece of the November Health Affairs Journal Club meeting is “Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicines.” In the paper, to appear in the November 2021 issue of the journal, author Kevin Outterson of the Boston University School of Law, examines policy initiatives under way in the US and UK that […]
Pandemic Prevention: How Europe Can Lead the Fight against AMR
The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. The World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, and major surgery will become too dangerous to […]
Exploring Opportunities to Reform Antimicrobial Payment and Post-Market Incentives
A public meeting hosted by the Margolis Center for Health Policy at Duke University, Washington, DC